Sequenom Announces Participation at the Bank of America Merrill Lynch Health
SAN DIEGO, May 7, 2012
SAN DIEGO, May 7, 2012 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life
sciences company providing innovative genetic analysis solutions, today
announced the Company's participation at the Bank of America Merrill Lynch
Health Care Conference at the Encore at the Wynn Hotel in Las Vegas, NV on May
Ronald M. Lindsay, Ph.D., Director and EVP of Research and Development, will
present on Tuesday, May 15, 2012 beginning at 1:00 p.m. PDT, to provide an
overview of and update on the Company. The presentation is expected to last
approximately 30 minutes and will be webcast live through the "Investors"
section of the Sequenom website at www.sequenom.com. An audio replay will be
available for 30 days following the initial presentation webcast.
Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to
improving healthcare through revolutionary genetic analysis solutions.
Sequenom develops innovative technology, products and diagnostic tests that
target and serve discovery and clinical research, and molecular diagnostics
markets. The company was founded in 1994 and is headquartered in San Diego,
California. Sequenom maintains a website at http://www.sequenom.com to which
Sequenom regularly posts copies of its press releases as well as additional
information about Sequenom. Interested persons can subscribe on the Sequenom
website to email alerts or RSS feeds that are sent automatically when Sequenom
issues press releases, files its reports with the Securities and Exchange
Commission or posts certain other information to the website.
SOURCE Sequenom, Inc.
Press spacebar to pause and continue. Press esc to stop.